Substance Information

Substance information

Infocards are automatically generated based on industry data. What is an infocard?

Substance Infocard

IC

Hydrocortisone

Help Substance identity

The ‘Substance identity’ section is calculated from substance identification information from all ECHA databases. The substance identifiers displayed in the InfoCard are the best available substance name, EC number, CAS number and/or the molecular and structural formulas.

Some substance identifiers may have been claimed confidential, or may not have been provided, and therefore not be displayed.

EC (European Community) Number

The EC Number is the numerical identifier for substances in the EC Inventory. The EC Inventory is a combination of three independent European lists of substances from the previous EU chemicals regulatory frameworks (EINECS, ELINCS and the NLP-list). More information about the EC Inventory can be found here.

If the substance was not covered by the EC Inventory, ECHA attributes a list number in the same format, starting with the numbers 6, 7, 8 or 9.

The EC or list number is the primary substance identifier used by ECHA.

CAS (Chemical Abstract Service) registry number

The CAS number is the substance numerical identifier assigned by the Chemical Abstracts Service, a division of the American Chemical Society, to substances registered in the CAS registry database. A substance identified primarily by an EC or list number may be linked with more than one CAS number, or with CAS numbers that have been deleted. More information about CAS and the CAS registry can be found here.

Molecular formula

The molecular formula identifies each type of element by its chemical symbol and identifies the number of atoms of each element found in one discrete molecule of the substance. This information is only displayed if the substance is well–defined, its identity is not claimed confidential and there is sufficient information available in ECHA’s databases for ECHA’s algorithms to generate a molecular structure.

Molecular structure

The molecular structure is based on structures generated from information available in ECHA’s databases. If generated, an InChI string will also be generated and made available for searching. This information is only displayed if the substance is well-defined, its identity is not claimed confidential and there is sufficient information available in ECHA’s databases for ECHA’s algorithms to generate a molecular structure.

More help available here.

EC / List no.: 200-020-1

CAS no.: 50-23-7

Mol. formula: C21H30O5

formula
Help Hazard classification and labelling

The ‘Hazard classification and labelling’ section shows the hazards of a substance based on the standardised system of statements and pictograms established under the CLP (Classification Labelling and Packaging) Regulation. The CLP Regulation makes sure that the hazards presented by chemicals are clearly communicated to workers and consumers in the European Union. The CLP Regulation uses the UN Global Harmonised System (GHS) and European Union Specific Hazard Statements (EUH).

This section is based on three sources for information (harmonised classification and labelling (CLH), REACH registrations and CLP notifications). The source of the information is mentioned in the introductory sentence of the hazard statements. When information is available in all sources, the first two are displayed as a priority.

Please note:

The purpose of the information provided under this section is to highlight the substance hazardousness in a readable format. It does not represent a new labelling, classification or hazard statement, neither reflect other factors that affect the susceptibility of the effects described, such as duration of exposure or substance concentration (e.g. in case of consumer and professional uses). Other relevant information includes the following:

  • Substances may have impurities and additives that lead to different classifications. If at least one company has indicated that the substance classification is affected by impurities or additives, this will be indicated by an informative sentence. However, substance notifications in the InfoCard are aggregated independently of the impurities and additives.
  • Hazard statements were adapted to improve readability and may not correspond textually to the hazard statements codes description in the European Union Specific Hazard Statements (EUH) or the UN Global Harmonised System (GHS).

To see the full list of notified classifications and to get more information on impurities and additives relevant to classification please consult the C&L Inventory.

More information about Classification and Labelling is available in the Regulations section of ECHA website.

More help available here.

Harmonised classification and labelling (CLH)

Harmonised classification and labelling is a legally binding classification and labelling for a substance, agreed at European Community level. Harmonisation is based on the substance’s physical, toxicological and eco-toxicological hazard assessment.

The ‘Hazard classification’ and labelling section uses the signal word, pictogram(s) and hazard statements of the substance under the harmonised classification and labelling (CLH) as its primary source of information.

If the substance is covered by more than one CLH entry (e.g. disodium tetraborate EC no. 215–540–4, is covered by three harmonisations: 005–011–00–4; 005–011–01–1 and 005–011–02–9), CLH information cannot be displayed in the InfoCard as the difference between the CLH classifications requires manual interpretation or verification. If a substance is classified under multiple CLH entries, a link to the C&L Inventory is provided to allow users to view CLH information associated with the substance and no text is automatically generated for the InfoCard.

It is possible that a harmonisation is introduced through an amendment to the CLP Regulation. In that case, the ATP (Adaptation to Technical Progress) number is displayed.

More info on CLH can be found here.

Classification and labelling under REACH

If available, additional information on classification and labelling (C&L) is derived from REACH registration dossiers submitted by industry. This information has not been reviewed or verified by ECHA, and may change without prior notice. REACH registration dossiers have greater data requirements (such as supporting studies) than do notifications under CLP.

Notifications under the Classification Labelling and Packaging (CLP) Regulation

If no EU harmonised classification and labelling exists and the substance was not registered under REACH, information derived from classification and labelling (C&L) notifications to ECHA under CLP Regulation is displayed under this section. These notifications can be provided by manufacturers, importers and downstream users. ECHA maintains the C&L Inventory, but does not review or verify the accuracy of the information.

Note that for readability purposes, only the pictograms, signal words and hazard statements referred in more than 5% of the notifications under CLP are displayed.

GHS08: Serious Health Hazard

Warning! According to the classification provided by companies to ECHA in CLP notifications this substance is suspected of damaging fertility or the unborn child and may cause damage to organs through prolonged or repeated exposure.

Helpful information About this substance

This section provides an overview of the calculated volume at which the substance is manufactured or imported to the European Economic Area (EU28 + Iceland, Liechtenstein and Norway). Additionally, if available, information on the use of the substance and how consumers and workers are likely to be exposed to it can also be displayed here.

The use information is displayed per substance life cycle stage (consumer use, in articles, by professional workers (widespread uses), in formulation or re-packing, at industrial sites or in manufacturing). The information is aggregated from the data coming from REACH substance registrations provided by industry.

For a detailed overview on identified uses and environmental releases, please consult the registered substance factsheet.

Use descriptors are adapted from ECHA guidance to improve readability and may not correspond textually to descriptor codes described in Chapter R.12: Use Descriptor system of ECHA Guidance on information requirements and chemical safety assessment.

The examples provided are generic examples and may not apply to the specific substance you are viewing. A substance may have its use restricted to certain articles or products and therefore not all the examples may apply to the specific substance. Furthermore, some substances can be found in an article, but with unlikely exposure (e.g. inside a watch) or with very low concentrations considered not to pose risks to human health or the environment.

Please note:

For readability purpose, only non-confidential use descriptors occurring in more than 5% of total occurrences are displayed.

The described Product category (i.e. the products in which the substance may be used) may refer to uses as intermediate and under controlled conditions, for which there is no consumer exposure.

More help is available here.

This substance is manufactured and/or imported in the European Economic Area for industrial use resulting in the manufacture of another substance (use of intermediates).

This substance is used at industrial sites and in manufacturing.

Consumer Uses

ECHA has no public registered data indicating whether or in which chemical products the substance might be used. ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

Article service life

ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment. ECHA has no public registered data indicating whether or into which articles the substance might have been processed.

Widespread uses by professional workers

ECHA has no public registered data indicating whether or in which chemical products the substance might be used. ECHA has no public registered data on the types of manufacture using this substance. ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

Formulation or re-packing

ECHA has no public registered data indicating whether or in which chemical products the substance might be used. ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

Uses at industrial sites

This substance has an industrial use resulting in manufacture of another substance (use of intermediates).
This substance is used for the manufacture of: chemicals.
Release to the environment of this substance can occur from industrial use: as an intermediate step in further manufacturing of another substance (use of intermediates).

Manufacture

Release to the environment of this substance can occur from industrial use: manufacturing of the substance.

Help How to use it safely

This section provides links to the list of precautions (precautionary statements) and to the guidance on safe use, if they have been provided in REACH registration dossiers.

  • Precautionary statements - describe recommended measures to minimise or prevent adverse effects resulting from exposure to a hazardous product or improper storage or handling of a hazardous product.
  • Guidance on safe use - recommendations by substance registrant on the proper use of the substance in various situations. Examples include recommended measures on fire-fighting, transport and recycling and disposal.

Please note: Precautionary measures and guidance on safe use concern the use and handling of the specific substance as such, not of the presence of the substance in other articles or mixtures. The precautionary measures and guidance on safe use are as submitted to ECHA by registrants under the REACH Regulation. Information on precautionary measures and the safe use is submitted by the registrant of a substance and the registrant is solely responsible for its accuracy and completeness.

More help available here.

about INFOCARD - Last updated: 05/12/2019 InfoCard

The InfoCard summarises the non-confidential data of a substance held in the databases of the European Chemicals Agency (ECHA). InfoCards are generated automatically based on the data available at the time of generation.

The quality and correctness of the information submitted to ECHA remains the responsibility of the data submitter. The type of uses and classifications may vary between different submissions to ECHA and for a full understanding it is recommended to consult the source data. Information on applicable regulatory frameworks is also automatically generated and may not be complete or up to date. It is the responsibility of the substance manufacturers and importers to consult official publications, e.g. the electronic edition of the Official Journal of the European Union.

InfoCards are updated when new information is available. The date of the last update corresponds to the publication date of the InfoCard and not necessarily to the date in which the update occurred in the source data.

More help available here.

Help Help

Key datasets

Help Help

Regulatory context

Here you can find all of the regulations and regulatory lists in which this substance appears, according to the data available to ECHA. This substance has been found in the following regulatory activities (directly, or inheriting the regulatory context of a parent substance):

REACH - Registration, Evaluation, Authorisation and Restriction of Chemicals Regulation
CLP - Classification, Labelling and Packaging
  • A list of substances for which classification and labelling data have been notified to ECHA by manufacturers or importers.
Previous Legislations
  • Substances listed in the EINECS, ELINCS, or NLP inventories.
Help Help

Substance names and other identifiers

Regulatory process names
11-beta-Hydrocortisone
Other
11-beta-Hydroxycortisone
Other
11beta,17,21-Trihydroxypregn-4-ene-3,20-dione
Other
11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione
Other
17-Hydroxycorticosterone
Other
17alpha-Hydroxycorticosterone
Other
4-Pregnene-11beta,17alpha,21-triol-3,20-dione
Other
Acticort
Other
Aeroseb-HC
Other
Ala-Scalp
Other
Alacort
Other
Algicirtis
Other
Amberin
Other
Anflam
Other
Anti-inflammatory hormone
Other
Anucort
Other
Anucort-HC
Other
Anusol HC
Other
Aquacort
Other
Aquanil HC
Other
Balneol-HC
Other
Barseb HC
Other
Basan-Corti
Other
Beta-HC
Other
Cetacort
Other
Clear aid
Other
Cleiton
Other
Cobadex
Other
Colocort
Other
Compound F (kendall)
Other
Cort-Dome
Other
Cortanal
Other
Cortef
Other
Cortenema
Other
Cortesal
Other
Corticreme
Other
Cortifan
Other
Cortiment
Other
Cortisol
Other
Cortisol alcohol
Other
Cortisolonum
Other
Cortisporin Otico
Other
Cortispray
Other
Cortolotion
Other
Cortonema
Other
Cortoxide
Other
Cortril
Other
Cremesone
Other
Cremicort-H
Other
Cutisol
Other
Delacort
Other
Derm-Aid
Other
Dermacort
Other
Dermaspray
Other
Dermil
Other
Dermocortal
Other
Dermolate
Other
Dihydrocostisone
Other
Dioderm
Other
Dome-cort
Other
Domolene-HC
Other
Efcorbin
Other
Efcortelan
Other
Eldecort
Other
Eldercort
Other
Epicort
Other
Epiderm H
Other
Esiderm H
Other
Evacort
Other
Ficortril
Other
Flexicort
Other
Foille Insetti
Other
Genacort
Other
Genacort (lotion)
Other
Glycort
Other
Gyno-Cortisone
Other
H-Cort
Other
HC #1
Other
HC #4
Other
HC (hydrocortisone)
Other
Heb Cort
Other
HI-Cor
Other
Hidalone
Other
Hidro-colisona
Other
Hidrocortisona
Other
Hycort
Other
Hycortol
Other
Hycortole
Other
Hydrasson
Other
Hydro-Adreson
Other
Hydro-Colisona
Other
Hydro-RX
Other
Hydrocorticosterone
Other
Hydrocortisone
EC Inventory, Pre-Registration process, Other
Hydrocortisone alcohol
Other
Hydrocortisone free alcohol
Other
Hydrocortisone in absorbase
Other
Hydrocortisone, topical
Other
Hydrocortisonum
Other
Hydrocortisyl
Other
Hydrocortone
Other
Hydroxycortisone
Other
Hytisone
Other
Hytone
Other
Hytone lotion
Other
Idrocortisone
Other
Incortin-H
Other
Incortin-hydrogen
Other
Kendall's compound F
Other
Komed HC
Other
Kyypakkaus
Other
Lactisona
Other
Lubricort
Other
Maintasone
Other
Meusicort
Other
Mildison
Other
Milliderm
Other
Neosporin-H Ear
Other
Nogenic HC
Other
Nutracort
Other
Optef
Other
Otosone-F
Other
Penecort
Other
Permicort
Other
Polcort H
Other
Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11-beta)-
Other
Pregn-4-ene-3,20-dione, 11beta,17,21-trihydroxy-
Other
Prevex HC
Other
Proctocort
Other
Proctofoam
Other
Proctosol-HC
Other
Proctozone HC
Other
Rectasol-HC
Other
Rectoid
Other
Reichstein's substance M
Other
Remederm HC
Other
Sanatison
Other
Scalp-Cort
Other
Scalpicin Capilar
Other
Sigmacort
Other
Signef
Other
Stie-Cort
Other
Stiefcorcil
Other
Synacort
Other
Systral Hydrocort
Other
Tarcortin
Other
Texacort
Other
Texacort lotion 25
Other
Timocort
Other
Transderma H
Other
Traumaide
Other
Uniderm
Other
CAS names
Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11.beta.)-
Other
IUPAC names
(11β)-11,17,21-trihydroxypregn-4-ene-3,20-dione
C&L Inventory
(1R,3aS,3bS,9aR,9bS,10S,11aS)-1,10-dihydroxy-1-(2-hydroxyacetyl)-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one
Other
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
C&L Inventory, Other
10R,11S,13S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
C&L Inventory
11,17,21-diidrossi-pregn-4-ene-3,20-dione-(11β)
C&L Inventory
11,17,21-trihydroxypregn-4-ene-3,20-dione
C&L Inventory, Registration dossier
11β)-11,17,21-trihydroxypregn-4-ene-3,20-dione
C&L Inventory
11β,17,21-Trihydroxypregn-4-en-3,20-dion
C&L Inventory
11β,17,21-Trihydroxypregn-4-ene-3,20-dione
C&L Inventory, Registration dossier
11β,17,21-Trihydroxypregn-4-ene-3,20-dione.
C&L Inventory
11β,17α,21-Trihydroxypregn-4-ene-3,20-dione
Registration dossier
8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
C&L Inventory
hydrocortisone acetate
C&L Inventory
Trade names
Hydrocortison Acetate
C&L Inventory
ZK 5191
Registration dossier
Other identifiers
1050676-88-4
Other
CAS number
1436392-18-5
Other
CAS number
50-23-7
EC Inventory, C&L Inventory, Registration dossier, Pre-Registration process, Other
CAS number
8056-08-4
Other
CAS number
80562-38-5
Other
CAS number
8063-42-1
Other
CAS number

Categories Display